Imprimir

Publicaciones Internacionales - José Peña

 

  1. Villanueva, E.; Castilla, J.; Gisbert-Calibuig, G.A. y Peña, J. (1972) Quotient K/L des inmunoglobulines cheines type K et L des proteins de Bence Jones posibilite d'une aplication medicolegales au diagnostic indivudual du sang. Login.et Dommage Cr., 5:57-62.

  2. Huber, B., Peña, J. and Festenstein, H. (1973) Spleen cell trans­plantion in mice; influence of non H-2 M-Locus in graft versus host and versus graft reaction. Transplantation Procceding, 5:1373.

  3. Peña, J., Huber, B. and Festenstein, H. (1973) The influence of H- 2 M-Locus spleen colony formation after allogeneic bone marrow transplantation in irradiated mice, assayed by Fe-59 uptake and colony couting. Transplantation Procceding, 5:1393-1397. IP: 01

  4. Sachs, J.A., Huber, B., Peña, J. and Festenstein, H. (1973) Gene­tic studies and effect on skin allograft survival of DBA/2, ly and M-locus antigens. Transplantation Procceding, 5:1383. IP: 01

  5. Festenstein, H. and Peña, J. (1975) Mixed lymphocytes reaction stimulating antigens, their detection, their selection to disea­se, and other markers of the major histocompatibility system. Annals of the Rheumatic Diseases, 34:7-18. IP: 01

  6. Peña, J., Schirrmacher, V., Garrido, F. and Festenstein, H. (1975) A radioassay for macrophage membrane antigens and its applica­tion for testing macrophage membrane antigens. Journal of Immu­nogenetics, 2:403-411. IP: 1,62

  7. Shirrmacher, V., Peña, J. and Festenstein, H. (1975) Specific lymphocyte-activiting determinants expreased on macrophages. Nature 255:155-156. # IP: 19,40 #

  8. Peña, J. and Festenstein, H. (1975) New mixed lymphocyte microcul­ture test harvested by a simple devise developed for this purpose. Transplantation, 20:26-39. IP: 3,6

  9. Mora, F., Quesada, T., Peña, J., Osorio, C. y Saw, S.G. (1976) An immunological study of nine proteins in CSF serum of a group apileptic patients. Clinica Chimica Acta, 80:55-59. IP:  2,38

  10. Fuente, M. de la; Barriga, C.; Alonso, A. y Peña, J. (1980) "Efecto de un nuevo C‑nucleosido sintético sobre el crecimiento de células de tumor ascítico de Ehrilich". Archivos de Farmacología y Toxicología, 6:247.

  11. Fuente, M. de la, Alonso, A., Barriga, C., y Peña, J. (1981) A Study of some pharmacological effects of a new synthetic c-nucleoside. Il Farmaco, Edicione Scientifica. 36;8:733-739

  12. Fuente, M. de la; Roman, E. y Peña, J. (1982) "LYDTO". Drugs of the Future,  7 (10): 742.

  13. Peña, J., Alonso, A., Caballero, MJ. y Requena F. (1982). A new method of radioimmunoassay by simultaneous filtration using a microharvester. Clinica Chimica Acta 119: 129-132.  IP:  2,38

  14. Alonso, M.C.; Fuente, M. de la; Hierro, J.M.; Solana, R. and Peña, J. (1983) "Effect of cyproheptadine on gastric secretion in rats". Methods and Finding. 5 (3): 177‑179. IP:  1,03

  15. Zafra, C., Fuente, M. de la, Gaytan, F., Solana, R. y Peña, J. (1984) Effect of fiblaferon-L on the human immune system. Chemot­herapy, 3O:131-136. IP:  0,5

  16. Solana, R., Alonso, M.C., Fuente, M. de la, Ortiz, P., Paniagua, J.A., Rojas, R. y Peña, J. (1984) Effect of phorbol esther TPA on macrophage metabolic activity. Methods and Finding. 6(1):67-71. IP:  1,03

  17. Fuente, M. de la, Fernandez-Motta, M., Zafra, C., Solana, R. y Peña, J. (1984) Effect of a new synthetic C-nucleoside (EDTO) on cell proliferation. Methods and Findings Exptl Clin Pharmacol. 6(5):241-243. IP:  1,03

  18. Alonso, M.C., Solana, R., Torres, A., Fuente, M. de la y Peña, J. PHA reactivity of spontaneous AKR lymphomas: absolute macrophage requirement. Allergology et. Immunopathology. 12, 5: 363-367 IP:  0,79

  19. Fuente, M. de la, Fernandez, M.M. and Peña, J. (1985) Inhibition of cell proliferation by a synthetic nucleoside (EIT). Chemotherapy, 31:383. IP:  0,5

  20. Alonso, M.C., Torres, A., Solana, R., Manzanares, M.R., García-Castellano, J.M. and Peña, J. (1985) Alteration in CFG-GM in preleukemic and leukemic AKR/J mice. Leukemia Research. Folia Biologica 31:193. IP:  2,55

  21. Alonso, M.C., Solana, R., Navarrete, C., Ramirez, R., To­rres, A., Peña, J. y Festenstein, H. (1985) Study of the antigenic profile of normal myelo-monocytic progenitors and leukaemic cell  lines using monoclonal antibodies. Leukocyte Typing II: Human myelaid and hematopoietic cells. Reinhertz et al. (eds). Springer Verlag. New York. 3:306. IP:  0,1

  22. Alonso, M.C., Navarrete, C., Solana, R., Torres, A., Peña, J. y Festenstein, H. (1985) Differential expression of HLA-DR and HLA- DQ antigens on normal cells of the myelomonocytic lineage. Tissue Antigens 26:31O-317. IP:  3,02.

  23.  Román, F.; Berlanga, J.A.; Urquía, M ; Guerra, F. y Peña, J. (1986) “Test de degranulación de basófilos humanos. Variantes técnicas aportadas”. Alergology y Immunopathology (14,4), 387-293. IP:  0,77

  24. García-Espejo, R., Alonso, M.C., Solana, R., Pera, C. and Peña, J. (1986) Expression of HLA molecules on cells from fresh ex­plants of human digestive tract cancer. Journal of Immunogene­tics 13:211-217. IP:  1,62

  25. Alonso, M.C., Navarrete, C., Solana, R., Ramirez, R., Peña, J. and Festenstein, H. (1986) Modulation of the expression of HLA class II Antigens by gamma interferon and phorbol ester TPA on myeloid leukaemic cell lines. Journal of Immunogenetics 13:255-261. IP:  1,62

  26. Alonso M.C., Serrano R., Peña J. (1987) Studies with monoclonal antibodies recognizing functional antigens C3bi receptor, LFA-1 molecule and Fc receptor". Leukocyte Typing III. E. Mc Michael et al. Oxford University Press. IP:  0,1

  27. Zafra, C., Peña, J. y de la Fuente, M. (1988) Effect of Microwa­ves on the activty of murine macrophages in vitro. Int. Archs Allergy. Appl. Immununol. 85:478-482. IP:  0,1

  28. Santamaría, M., Molina, I., Muñoz, E., López, A., Toro, M. y Peña, J. (1988) Identificaion nd characterization of a humn cell line wih dendritic cell features. Virchows Archiv B Cell Pahtology 56:77-83. IP:  2,33

  29. Urquía, M. de.; Monserrat, J.; Santamaría, M. Guerra, F.; Cutando, A. y Peña, J. (1988) "Determination of cell membrane bound IgE in allergic patients and healthy controls ‑a new technology‑. Allergologia et immunopathologia. 16: 299‑304. IP:  0,77

  30. Santamaría, M., Muñoz, E.,  Molina I., Ortega, M.C. and Peña, J. (1989) Immunomodulation of HLA class I and II expression on a human tumor derived cell line by 5-azacytidine, bacterial lipo­polyssaccharide, gamma interferon and a phorbol ester. Finding in Experimental and Clinical Pharmacology. 11:269- 272. IP:  0,1

  31. Alonso, C., Serrano, R., Solana, R. and Peña, J. (1989) Natural killer susceptibility of brain tumor cell lines inversely corre­lates with the degree of cell differentiation and not with the level of human leukocyte antigen expression. International Archives Allergy Applied Immunology 88:169-172. IP: 0,1

  32. Serrano R, Alonso C, Solana R, Monserrat J, Muñoz J and Peña J. (1989) Identification of a new tumour factor inducing resitence to NK cell lysis. Immunology Letters. 20:311-316. IP: 2,51

  33. Fuente de la M, Alonso MC, Solana R and Peña J. (1989) Macrophage and lymphocyte antibody-dependent cellular cytotoxi­city in spontanegus leukemogenesis of AKR/J mice. Tumor Biology. 10:310-315. IP: 2,02

  34. Quesada M, Solana R, Santamaría M, Martín Malo A, Aljama P and Peña J. (1989) Effect of calcitriovol on NK activity on hemodyalized patients. J. Steroid Biochem. 34:423-425. IP: 2,88

  35. Peña J, Solana R, Alonso MC, Santamaría M, Serrano R, Ramirez R and Carracedo J. (1989) MHC expression on tumour cells and their susceptibility to NK cytotoxicity. Journal of Immunogenetic. 16:407-417.  IP: 1,62

  36. Villanueva JL, Rivera J, Ogea JL, Ortega C, López-Beltran A, Peña J and Santamaría M. (1990) Evolution to extramedullary plasmacytoma in a patient with primary sjogren's syndrome. Arthritis and Reumatism. 33:150-151. IP: 8,43

  37. Villanueva JL, Solana R, Alonso MC and Peña J. (1990) Changes in the expression of HLA-clase II antigens on peripheral blood monocytes from aged humans. Disease Markers. 8:85-91. IP: 1,72

  38. Solana R, Alonso C, Ramirez R, Carracedo J, Serrano R, Yiangou Y y Peña J. (1990) Analysis of the Mechamisms involved in NK resistance induced by a new tumor factor NK-RIF. Cellular Immunology 130:244-251. IP: 2,57

  39. Peña J, Alonso MC, Solana R, Serrano R, Carracedo J and Ramirez R (1990) Natural killer susceptibility is independent of HLA clas I antigen expression on cell lines obtained from human solid tumors. European Journal of Immunology. 20:2445-2449 IP: 4,94.

  40. Serrano R, Yiangou Y, Solana R, Sachs JA and Peña J (1990) Isolation of a novel tumour protein which induces resistance to NK lysis. Journal of Immunology. 145:3516-3523. IP: 5,74

  41. Serrano, R.; Yiangou, Y.; Solana, R.; Bloom, S., Peña, J. and Festenstein, H. (1990) "Effects of prepro‑vip derived peptides on murine immune response".Journal of  Neuroimmunology 29:5‑72. IP: 2,90.

  42. Peña J, Serrano R and Solana R (1991) MHC antigens in NK cell recognition and lysis. Immunology Today 12:95. IP: 0,5

  43. Marubayashi M, Solana R, Ramirez R, Aranda E, Galan F and Peña J (1991) Sera from patients with colon, breast and lung cancer induce resistance to lysismediated by NK cytotoxic fac­tors (NKCF). British Journal of Cancer. 63:114-117.  IP: 4,83

  44. Serrano I, Quesada JM, Borrego F, Fernández N, Peña J and Solana R (1991) In vitro effect of 1,25-dihydroxyvitamin D3 (1,25-OH2D3) on NK cell cytotoxycity. Vitamin D Gene Regulation Structures-Function Analysis and Clinical Application. 496-497.

  45. García-Plata D, Mozos E, Sierra MA, Peña J and Solana R (1991) HLA expression in basal cell carcinomas. Invasion and Metastasis. 11:166-173. IP: 0,1

  46. Solana, R.; Villanueva, J.L.; de la Fuente, M. and Peña, J. (1991) "Cell mediated immunity in ageing". Comparative Biochemistry Physiology. 99A: 1‑4. IP: 2,13

  47. Santamaría M, Marubayashi M, Arizon JM, Montero A, Concha M, Valles F, López F and Peña J (1992) The activa­tion antigen CD69 is selectively expressed on CD8+ endomyocardium infiltrating T lymphocytes in human rejecting heart allografs. Human Immunology 33:1-4. IP: 2,87

  48. Peña J and Solana R (1992) Histocompatibility antigens and natural killer susceptibility. Immunology Research. 11:130-140. IP: 0,5

  49. Ramirez R, Solana R, Carracedo J, Alonso MC and Peña J (1992) Mechanisms involved in NK resistance induced by interferon-γ. Cell Immunology 140:248-256. IP: 0,5

  50. Muñoz E, Blazquez MV, Madueño JA, Rubio G and Peña J (1992)  CD26 induces T cell proliferation by tyrosine protein phosphorylation. Immunology 77:43-50. IP: 3,30

  51. Solana R, Romero J, Alonso MC and Peña J (1992)  MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21ras)levels in human breast tumors. Invasion Metastasis 12:210-217. IP: 0,5

  52. Blazquez MV, Madueño JA, Gonzalez R, Jurado R, Bachovchin WW, Peña J and Muñoz E (1992)  Selective decrease of CD26 expression in T cells form HIV-1 infected individuals. Journal of Immunology 149:3073-3077. IP: 5,74

  53. Borrego, F.; Peña, J. and Solana, R. (1992) "Different involvement of Protein Kinase C and Protein Tyrosine Kinases on CD69 expression by NK cells triggered via different surface receptors."  Natural Immunity. 11:286. IP: 0,5

  54. Borrego, F.; Peña, J. and Solana, R. (1992) "Role of Protein Kinases on NK cell activities induced by IL‑2: a comparative study".Natural Immunity 11:292. IP: 0,5

  55. Villanueva JL, Gónzalez-Dominguez J, Gónzalez-Fernández R, Prada JL, Peña J, Solana R. (1993) HLA antigen familia study in complete Behcet syndrome affecting three sis­ters. Annals of the Rheumatic Diseases 52(2):155-157. IP: 0,1

  56. Madueño JA, Muñoz E, Blazquez MV, Gonzalez R, Aparicio P, Peña J. (1993) The CD26 antigen is coupled to protein tyrosine phosphorylation and implicated in CD16 mediated lysis in NK cells. Scandinavian Journal of Immunology. 37:425-429. IP: 1,93

  57. Borrego F, Peña J and Solana R. (1993) Regulation of CD69 ex­pression on human NK cells: Differential involvement of protein kinase C and protein tyrosine kinases. European Journal of Inmunology. 23:1039-1043. IP: 4,94

  58. Marubayashi M, Fernández-Arcas N, García-Cozar FJ, Montero A, Arizón JM, Concha M, Peña J and Santamaría M. (1993) Proliferation and activation of endomyocardium infiltrating lymphocytes derived from allografted human hearts require IL-4. Clinical Transplantation 7:567-570. IP: 1,75

  59. Cuadrado MJ, Marubayashi M, Ortega C, Fernández-Arcas N, García-Cozar F, Peña J, Sánchez-Guijo P and Santamaría M. (1993) Relationship of IL-2, IL-2R (CD25+), soluble IL-2R and IL-4 with disease activity in SLE patiens. Lupus 1:1-4. IP: 2,60

  60. Solana, R. and Peña, J. (1994) Natural killer cell receptors: Activa­tion and inhibition of NK cell mediated cytotoxicity en MHC antigens and NK cells. Edit. Landes Co. USA.

  61. Peña, J. and Solana, R. (1994) Effect of target cell histocompatibi­lity antigens in NK cell mediated recognition and lysis in MHC antigens on NK cells.Edit. Landes Co. USA,

  62. Borrego F.; López-Beltrán, A.; Peña, J. and Solana, R. (1994) Downregulation of Fcg Receptor IIIAa (CD16-II) on Natural Killer Cells Induced by Anti-CD16 mAb is independent of Protein Tyrosine Kinases and Protein Kinase C. Cellular Immunology. 158:208-217. IP: 2,57

  63. Borrego, F.; García-Cozar, F.; Madueño, J.A.; Galiani, M.D.; Santamaría, M.; Peña, J. and Solana, R. (1994) CD69 expression and function on NK cells. Tissue Antigens. 42(4). IP: 3,02

  64. Galiani, M.D.; Borrego, F.; Madueño, J.A.; Pérez-Bermejo, L.; Peña, J. and Solana, R. (1994) Phenotypic and functional characterization of anti-NK mAbs using resting NK cells. Tissue Antigens. 42(4). IP: 3,02

  65. Borrego, F.; Galiani, M.D.; Pérez-Bermejo, L.; Peña, J. and Solana, R.(1994)  Expression of FCg receptors on NK cells. The downregulation of CD16 induced by CD16 rosslinking is PKC and PTK indepentent. Tissue Antigens. 42(4). 1994. IP: 3,02

  66. López-Beltrán, A.; Santamaría, M., García-Cózar, F.J.; Peña, J. Molina, I.J. (1994) CD43 is detected in paraffin ebedded sections of non-hematopoietic malignant tumors. Leukocyte Typing. IP: 0,1

  67. Borrego, F.; Galiani, M.D.; Madueño, J.A.; Pérez-Bermejo, L.; García-Cozar, F.J., Peña, J.; Santamaría, M.; Solana, R. (1995) Phenotypic and functional characterization of anti-NK mAbs using resting MK cells and the NK cell line YT. Leukocyte Typing V. (Scholsman et al, Eds.) Oxford University Press. Vol II: 1380-1384.

  68. Borrego, F., Galiani, M.D., Garcia‑Cozar, F., Madueño, J.A., Santamaria, M., Peña, J., Solana, R. (1995) CD69 expression and function on NK cells. Leukocyte Typing V (Scholsman et al, Eds.). Oxford University Press. Vol II: 1427-1430.

  69. Garcia‑Cozar, F., Borrego, F., Madueño, J.A., Solana, R., Molina I., Peña, J. and Santamaria, M. (1995) Costimulatory effect of workshop mAbs activation panel on T cell proliferation. Leukocyte Typing V (Scholsman et al, Eds.). Oxford University Press. Vol I: 1133-1136.

  70. Quesada, J. M.; Serrano, I.; Borrego, F.; Martín, A; Peña, R. Solana. (1995) Calcitriol effect on natural killer cells from hemodialyzed and normal subjects. Calcified Tissue International. 56: 113-117. IP: 2,75

  71. García-Cozar, F.; Molina, I.J.; Marabuyashi, M.; Cuadrado, M.J.; Peña, J. y Santamaría, M. (1996) Defective B7 expression on antigen presenting cells underlying T cell abnormalities in SLE patients. Clinical Experimental Immunology. 104:72-79. IP: 3,13

  72. Luque, I.; Solana, R.; Galiani, M.D.; Gónzalez, R.; García, F.; López de Castro, J.A.; and Peña, J. (1996) Threonine 80 on HLA-B27  confers protectioagainst lysis by group of natural killer clones. European Journal  of Immunology  26 : 1974-1977. IP: 4,94

  73. Fernández-Arcás, N.; Dieguez-Lucena, J.L.; García-Villanova, J.; Peña, J.Morell-Ocaña, M., and Reyes-Engel, A. (1996) Direct Quantification of  HIV-1 RNA          in human plasma by free solution capillary electrophoresis (FSCE). Journal of Acquired Immune deificiency sndromes and human retrovirology 12:107.111. IP: 4,26

  74. Santamaría, M.; López-Beltrán, A.; Toro, M. Peña, J. and Molina, I. (1996) Specific monoclonal antibodies aganinst leukocite-restricted cell surface  molecule CD43 react with Nonhematopoietic tumor cells. Cancer Research56:352- 3529. IP: 8,23

  75. Luque, I.; Galiani, D.; Gónzalez, R.; García, F.; López de Castro, J.A., Peña, J. y Solana, R. (1997)  Recognition of threonine 80 on HLA-B27 subtypes   by NK clones”. 12th IHWC Genetic Diversity of HLA (Charrony cols, eds) EDK Int. Paris.

  76. Peña, J.; Solana, R.; Borrego, F. and Roslad, B. (1997)  Methods to study the role of mayor histocompatibility complex in NK cell cytotoxicity. MHC Volumen 1 A practial Approach. Edited by Fernandez and G. Bucher. Editorial IRL. Press. Cap. 7: 91-106.

  77. Blázquez, Valle; Luque, I.; Collantes, E.; Aranda, E.; Solana, R.; Peña, J. y Muñoz, E. (1997) Cellular redox status influences both cytotoxic and NF-c B activation in natural killer cells”. Immunology 455-460. IP: 3,30

  78. Gallego, M.D; Santamaría, M; Molina, I. and Peña, J. (1997) Defective actin reorganization anda polymerization of  Wiskott-Aldrich T cells in response to CD3 mediate stimulation. Blood 90:3089-3097. IP: 10,55

  79. Collantes-Estévez, E.; Gónzalez Fernández, R.; Muñoz, E.;  Solana, R.; Peña, J. (1997) “Differences in lymphocyte typing for the antigen HLA-B27 resulting from the particular technique used in patients with ankylosing spondylitis”. British Journal of Reumatology. 36:125-128. IP: 0,5

  80. Galiani, M.D.; Aguado, E.; Tarazona, R.; Romero, P.; Molina, I; Santamaría, M.; Solana, R. y Peña, J. (1999) Expression of killer inhibitory receptors on cytotoxic cells from HIV-1 infected individuals. Clinical Experimental Immunology 155:472-477. IP: 3,13

  81. Borrego, F.; Alonso, C.; Galiani, M.D.; Carracedo, J.; Ramirez, R.; Ostos, B.; Peña, J. and Solana, R (1999)  NK pehnotypic markers and IL-2 response in NK cells from elderlpeople. Experimental  Gerontology. 34: (253-265). IP: 3,80

  82. Tarrazona, R.; Galiani, M.D.; López-Lluch, G.; Aguado, E.; Barahona, F.; Solana, R. and Peña, J. (1999) Effect of HLA class I derived peptides on NK cell activity in vitro. Human Immunlogy. Vol. 60. Supll. 1. (80). IP: 2,87

  83. Galiani, M.D.; Tarazona, R.; Borrego, F.; López, G.; Aguado, E.; Coligan, J.; Peña, J. and Solana, R. (1999) Recognition of HLA-CW3 antigen inhibits CD28-dependent killing of human YT cells transfected with KIR2DL2 NK  inhibitory receptor gene. Human Immunlogy. Vol. 60. Supll. 1. (80).  IP: 2,87

  84. Borrego, F.; Robertson, M.J.; Ritz, J.; Peña, J. and Solana, R. (1999) CD69 is stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor”. Immunologoy 97:159-165. IP: 3,30

  85. Solana, R.; Alonso, M.C.; Peña, J. (1999) “Natural killer cells in healthy aging”. Experimental Gerontology. 34:435-443. IP: 3,80

  86. Aguado, E., Santamaría, M., Gallego, M.D., Peña, J. y Molina, J. (1999). Functional expression of CD43 on human natural killer cells. Journal of Leukocyte Biology. 66:923-929. IP: 4,62

  87. González, R; de la Mata, M; de la Torre, J; Miño, G; Pera, C; Peña, J; Muñoz, E. 2000. Levels of HBV-DNA and HBsAg after acute liver allograft rejection treatment by corticoids and OKT3cal Transplantation. Clinical Transplantation. 2: 208-212. IP: 1,75

  88. Bene, MC ; Stockines, H; Napp, W; Zlabinger, G; Goldman, M; Taskoy, C; Rabatic, S; Fernandez-Cruz, E; Peña  J y otros (2000). State of the art of clinical immunology in European Immunology Letters, 71, 191-201. IP: 0,5

  89. Tarazona, R; Lopez-Lluch, G; Galiani, MD; Aguado, E; Barahona, F; Solana, R and Peña J (2000). HLA-B2702 (77-83/83-77) peptide binds to ss-tubulin on human NK cells and blocks their cytotoxic capacity. Journal Immunology 165:6776-6782. IP: 5,74

  90. Villanueva, J.L., Caballero, F.J., Del Nozal, B., Sánchez, B., Viciana, P., De Alarcón, A., y Peña, J. (2000). Peripheral blood natural killer cell reconstitution after highly active antirretroviral therapy. AIDS. 14, 3: 3-4. IP: 6,34

  91. Tarazona, R., Delarosa, O., Alonso, C., Ostos, B., Espejo, J., Peña, J. y Solana, R. (2000). Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mechanisms of Ageing and Development 121:77-88. IP: 0,5

  92. Gallego, M.D., Aguado, E., Kindelán, J.M., Peña, J., Santamaría, M. and Molina, I.J. (2001). Altered expression of CD43-hexasaccharide isoform on peripheral T lymphocytes from HIV-infected individuals.AIDS,15,4: 477-481. IP: 6,34

  93. Taradas, S., Tapas, M., Bhattacharyya, S., Mahapatra, P., Poddar, A., Roy, S., Peña, J., Solana, R., Tarazona, R. and Bhattacharyya, B. (2001). Role of the Carboxy-Termini of Tubulin on Its Chaperone-Like Activity. Proteins. 1: 262-273. IP: 0,1

  94. Aguado, E., Santamaría, M., Gallego, MD., Peña, J and Molina I. (2000) Expression and functional role of CD43 on human natural killer cells. Journal of  Leukocyte  Biology 28-33. IP: 4,62

  95. Peña, J., Villanueva, JL., Molina, I., Santamaría, M. y Solana, R. (2001). The role of NK cells in the progression of HIV infection. Journal Clinic Immunology. 1: 91-96. IP: 3,32

  96. Gallego, MD., Aguado, E., Kindelán, JM., Peña, J., Santamaría, M and Molina, I. (2001) Determination of truncated proteins and altered expression of CD43-hexasaccharideisoform on peripheral T lymphocytes from HIV-infected individuals. AIDS 15, 447-481. IP: 6,34

  97. Romero, P., Ortega, C., Palma, A., Molina, I., Peña, J. and  Santamaría, M. (2001). Expression of CD94 and NKG2 molecules on human CD4(+) T cells in response to CD3-mediated stimulation. Journal  Leukococyte  Biology 70, 219-224. IP: 4,62

  98. Galiani, MD., Garrido, J., Pérez de la Lastra, J.M., Solana, R; Peña, J and  Llanes D. (2001)  A new monoclonal antibody (JM1E3) specific for porcine SLA class I antigen recognizes HLA class I antigens and interferes with HLA recognition by human NK inhibitory receptors. Leukocyte Typing VII. 1,33-35.

  99. Borrego, F., Kabat, J., Ki Kim, D., Pena, J. and Solana, R. Structure and function of Major Histocompatibility Complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Molecular Immunology. 9: 637-661. IP: 2,91

  100. Tarazona, R., Casado, J., delaRosa, O., Torre-Cisneros, J., Villanueva, E., Sánchez, B., Galiani, MD., Peña, J. and Solana, R. (2001). Selective depletion of CD56dim NK cells subsets and maintenance of CD56bright NK cells in tratment-naive HIV-1 seropositive individuials. AIDS. 3: 176-183. IP: 6,34

  101. Tarazona, R., Borrego, F., Galiani, MD., Aguado, E., Peña, J. and Solana, R. (2001). Inhibition of CD28-mediated natural cytotoxicity by KIR2DL2 does not require p56lck in the NK cell line YT. Molecular Immunology. 38: 495-502. IP: 2,91

  102. Pérez-Guijo, V; Muñoz, E., Escudero, A., Veroz, R., Sánchez, M., Muñoz-Villanueva, MC., González, R., Pena, J and Collantes-Estévez, E. (2002). Distribution of HLA-DRB1 genes in patients with sporadic ankylosing spondylitis in the south of Spain. Joint Bone Spine. 69:458-462. IP: 2,46

  103. Lozano, JM., González, R., Kindelán, JM., Rouas-Freiss, N., Caballos, R., Dausset, J., Carosella, E. and Peña, J. (2002). Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS. 16: 347-351. IP: 6,34

  104. Tarazona, R., DelaRosa, O., Casado, J., Torre-Cisneros, J., Villanueva, JL., Galiani, MD., Peña, J. and Solana, R. (2002). NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56. AIDS.  16: 197-200. IP: 6,34

  105. DelaRosa, O., Tarazona, R., Casado J., Alonso, C., Ostos, B., Peña, J. and Solana, R. (2002) Valpha24(+) NKT cells are decreased in elderly humans. Experimental Gerontology. 37:213-215. IP: 3,80

  106. Román, C., Carmona, C., Solana, R. and Peña J. (2002). Contribution of new methodology to the study of specific HLA antibodies.  Inmunología 1, 17-18. IP: 0,5

  107. Lozano, JM., Padillo, J., Montero, JL., Pena, J., de la Mata, M. and Muntané, J. (2003). Immunomodulatory activity of TNF-alpha during acute liver injury induced by D-galactosamine and its protection by PGE in rats. Intertational Immunopharmacology. 3: 197-207. IP: 2,32

  108. Cabello, A., Rivero, A., García, MJ., Lozano, JM., Torre-Cisneros, J., González, R., Dueñas, G.,  Galiani, MD., Camacho, A., Santamaría, M., Solana, R., Montero, C., Kindelán, JM. and Pena, J. (2003), HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals: Human Immunology 64:1045-1049. IP: 2,87

  109. Lozano, JM, Ojeda, A. and Peña, J. 2033. New approaches in HLA-G. Inmunología. 3: 197-207. IP: 05.

  110. Ortega, C., Romero, P., Palma, A., Orta, T., Peña J., García-Vinuesa, A., Molina, I. and Santamaría, M. 2004. A role for NKG2-A and NKG-C surface receptors in chronic CD4+T cell response. Immunology and Cell Biology 82 (6), 587-595. IP: 3,74

  111. Chakraborty, S., Gupta, S., Poddar, A., Pena, J., Solana, R., Tarazona, R. and Bhatttacharyya, B. (2004). The B-ring substituent at C-7 of colchicine and the alpha- C-teminus of tubulin communicate through the “Tail-Body” interacion. Proteins: Structure, Function, and Genetics, 57: 602-609.

  112. Tarazona, R., Casado, JG., Soto, R., DelaRosa, O., Peralbo, E., Rioja, L., Pena, J and Solana, R, (2004). Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword? Cancer Immunology  Immunotherapy. 53, 911-924. IP: 4,29

  113. Casado, JG., Soto, R., DelaRosa, O., Peralbo, E., del CM-V, Rioja, L., Pena, J., Solana, R., Tarazona, R, (2005). CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype. Cancer Immunology  Immunotherapy 54:1162-1171. IP: 4,29

  114. Torres, MI., Lopez-Casado, MA., Luque, J., Peña, J. and Rios, A. (2006). New advances in celiac disease: serum and intestinal expresion of HLA-G. International  Immunology  18 (5) 713-718. IP: 3,30

  115. Lozano, JM., Kindelan, JM., Cabello, A., Gonzalez, R., Solana, R. and Peña J. (2006). IL-2 increased RANTES production and CD25 only from antiretroviral treated HIV-1+ patients with detectable viral loads. Intertational Immunopharmacology International, 6 (6):1034-8.  IP: 2,32

  116. Luque, J., Torres, MI., Aumente, MD., Marín, J., García-Jurado, G., Gonzalez, R., Pascual, D., Guerra, N., Lopez-Rubio, F., Alvarez-Lopez, MR., Arizon, JM. and Peña J. (2006). Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Human Immunolgy. 67 (4-5):257-263. IP: 2,87

  117. Luque, J., Torres, MI., Aumente, MD., Marín, J., García-Jurado, G., González, R., López-Rubio, F., Arizón, JM., and Pena J.(2006).  sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation. Transplant Immunology, 17: 70-73. IP: 1,91

  118. Rivero,  A., Lozano, JM., González, R., García-Jurado, G., Camacho, A., Torres-Cisneros, J. and Peña, J. (2007). Nucleoside Reverse Transcriptase Inhibitors are able and Protease Inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients. Human Immunoly. 68: 303-306. IP: 2,87

  119. Lozano, JM.,  DelaRosa, O., Garcia-Jurado, G., Luque, J., Solana, R., Kindelán, JM., Rivero,  A. and  Pena, J. (2007) Impaired response of HIV-1-specific CD8+ cells from anti-retroviral-treated patients. AIDS Res Human Retroviruses. 23: 1279-1282. IP: 2,08 

  120. Blanco, O., Tirado, I., Muñoz-Fernandez, R., Abadía-Molina, AC., García-Pacheco, JM., Peña, J. and Olivares, E. (2008) Human decidual stromal cells expreses HLA-G. Effect of cytokines and decidualization. Human Reproduction 23 (1): 144-152. IP: 4,35.

  121. Padillo, F.J., Cruz, A., Segura-Jiménez, I., Ruiz-Rabelo, J., Vázquez-Ezquerra, M.R., Perea-Álvarez, M.D., Peña, J., Briceño, J. and Muntané, J.: (2007) Effect of anti-TNF-α antibodies or bile duct drainage on cellular immunity and tissue injury in experimental obstructive jaundice in rats. International Journal Immunopathology Pharmacology.20(4):855-60. IP: 0,1

  122. Lozano, J.M., Luque, J., García-Jurado, G., Soriano-Sarabia, N., González, R., Vallejo, A., Leal, M. and Peña, J. (2008). NK-associated regulatory receptors in a structured HAART interruption of HIV-1+ individuals. AIDS Research and Human Retroviruses 24(8):1037-42. IP: 2,08

  123. Mestre, G.,  García, F., Martinez, E., Milinkovic, A.,  López, A., León, A, Mora, B.,  Argelich, R., Mallolas, J.,  Blanco, JL., Larrousse, M.,  Laguno, M.,  Gallart, T.,  Lozano, JM.,  Peña, J., Gatell, JM. and Plana, M.  (2008). Natural Killer Cells and Expression of KIR Receptors in Chronic HIV Type 1-Infected Patients After Different Strategies of Structured Therapy Interruption.  AIDS Research and Human Retroviruses. 24, 12:1-11. IP: 2,08

  124. Luque, J., Lozano, JM., García-Jurado, G., Soriano-Sarabia, N., González, R., Vallejo, A., Leal, M. and  Peña J.(2008). HLA-G in HIV Infection. Research and Human  Retroviruses. 2008, 24(8):1037-42. IP: 2,08

  125. Torres, M., Luque, J., Lorite, P., Isla-Tejero, B., Palomeque, T., Aumente, M., Arizon, JM., Peña, J. (2009). 14-bp polymorphism of HLA-G as genetic determinant in heart transplantation and cyclosporine therapy monitorization. Human Immunology 70, 830-35. IP: 2,87

  126. Lozano, JM., González, R., Luque, J., Frias, M., Rivero, A. and  Peña J. (2009)  CD8(+) HLA-G(+) Regulatory T Cells Are Expanded in HIV-1-Infected Patients. Viral Immunolology, 2009, 463-5. IP: 1,92

  127. Fainardi, E., Castellazzi, M., Stignani, M., Morandi, F., Sana, G., González, R., Pistoia, V., Baricordi, OR., Sokal, E. and Peña, J. (2010). Emerging Topics in HLA-G. Cellular and molecular life sciences (CMLS). 68, 433-51. IP: 7,04

  128. Fernández, S., Molina, I., Romero, P., González, R., Peña, J., Sánchez, F., Reynoso, F., Pérez-Navero, JL., Estevez, O., Ortega, C. and Santamaría, M. (2011), Characterization of Gliadin Specific Th17 Cells from the Mucosa of Celiac Disease Patients , American  Journal  Gastroenteroly. 106(3) 428-38. IP: 6,88

  129. García, F., Climent, N., Assoumou, L., Gil, C., González, N., Alcamí, J., León, A.,  Romeu, J., Dealmau, J., Martinez-Picado, J., Lifson, J., Autran, B., Costagliola, D., Clotet, B., Gatell, JM., Plana, M., Gallart T., and DCV2/MANON07 group (Peña, J., Benito, JM., Chonco, L.) (2011). A Therapeutic dendritic cell-based vaccine for HIV-1 infection. Journal of Infectious Diseases. 203, 473-78. IP: 6,28

  130. Silva, R., Moir, S., Kardava, L., Debell, K., Simhadri, V.R.,  Ferrando-Martínez, S.,  Leal, M., Peña, J.,  Coligan, JE,  and Borrego, F. (2011). CD300a is expressed on human B cells, modulates BCR mediated signaling and its expression is down-regulated in HIV infection. Blood. 117 (22) 5870-80. IP: 10,65

  131. García F, Climent N, Assoumou L, Gil C, González N, Alcamí J, León A, Romeu J, Dalmau J, Martínez-Picado J, Lifson J, Autran B, Costagliola D, Clotet B, Gatell JM, Plana M, Gallart T (2011). A therapeutic dendritic cell-based Vacine for HIV-1 infeccion. Journal of Infection Diseases DCV2/MANON07- AIDS Vaccine Research Objective Study Group. J Infect Dis.  15;203(4):473-8. IP:3,7

  132. Peña, J., Frias, M., Castro-Orgaz, L., González, R.,  García, F., Gallart, T., Gatell, JM., Plana, M., (2012) Effects of a therapeutic dendritic cell-based vaccine for HIV-1 infection on innate immunity. Viral Immunology, 25(1) 37-44 IP: 1,96.

  133. Rivero-Juárez, A., Camacho A., Neuka, K., González, R, Di Lello F.A, Pérez-Camacho I, Mesa P, Torre-Cisneros J, Peña J, Pineda J.A and Rivero A. (2012). LDLr Genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patients. AIDS. 26 (8) 1009-1015. IP: 6,34

  134. Estévez, O., Ortega, C., Tejero, A., Fernández, S., Aguado, R., Aróstegui, J.I, González-Roca, E., Peña J. and Santamaría M. (2013). A novel phenotuype variant of severe congenital neutropenia caused by G6PC3 deficiency. Pediatric Blood Cancer. 29-3. IP: 2,7

  135. Rivero-Juarez A., Camacho A., Caruz A.; Neukam K., Perez-Camacho I.; Gonzalez R.; Mira J.A.; Torre-Cisneros J.; Peña J.; Pineda J.A.; Rivero A.: (2013) Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients. PloS One. 16; 8: e61992. IP:,3,7

  136. Antonio Rivero-Juarez; Angela Camacho; Nicolas Merchante; Ines Perez-camacho; Juan Macias; Carmen Ortiz-Garcia; Celia Cifuentes; Julian Torre-Cisneros; Jose Peña; Juan A Pineda; Antonio Rivero (2013). Incidence of liver damage of uncertain origin in HIV Patients not Co-infected with HCV/HBV".  PloS One  8; 7;  e68953. IP: 3.7

  137. Rivero-Juárez, A., Camacho A., Merchante N.,  Pérez-Camacho I.,  Torre-Cisneros, J., Peña J., Pineda J.A., Rivero. A. (2013): High Incidence of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients without Hepatotropic Viral Co-infections. Plos One ; 8; 7; e6895. IP:3,7

  138. M. Frias, A. Rivero-Juarez, A. Gordon, A. Camacho, S. Cantisán, F. Cuenca-Lopez, J. Torre-Cisneros, J. Peña, and A. Rivero. (2014). Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune response. Journal of Innate Immunity (In press).

  139. Mothe, Beatriz; Climent, Nuria; Plana, Montserrat; Rosas, Miriam; Jimenez, Jose Luis; Muñoz-Fernandez, María de los Ángeles; Puertas, Maria Carmen; Carrillo, Jorge; Gonzalez, Nuria; Leon, Agathe; Pich, Judit; Arnaiz, Joan; Gatell, Jose; Clotet, Bonaventura; Blanco, Julià; Alcamí, José; Martinez-Picado, Javier; Alvarez-Fernandez, Carmen; Sanchez-Palomino, Sonsoles; Peña, Jose; Benito, Jose; Rallón, Norma; Gomez, Carmen; Perdiguero, Beatriz; Garcia-Arraiza, Juan; Esteban, Mariano; López, Juan; Brander, Christian; Garcia, Felipe. (2015) ,Safety and immunogenicity of a MVA-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1. Journal of Antimicrobial Chemotherapy (In press).